These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Short communication: Investigation of in vitro antibiotic susceptibility of Brucella melitensis]. Alişkan H, Turunç T, Demiroğlu YZ, Colakoğlu S, Arslan H. Mikrobiyol Bul; 2008 Jan; 42(1):125-9. PubMed ID: 18444570 [Abstract] [Full Text] [Related]
3. Actual antibiotic resistance pattern of Brucella melitensis in central Anatolia. An update from an endemic region. Tanyel E, Coban AY, Koruk ST, Simsek H, Hepsert S, Cirit OS, Tulek N. Saudi Med J; 2007 Aug; 28(8):1239-42. PubMed ID: 17676210 [Abstract] [Full Text] [Related]
4. In vitro antimicrobial susceptibility of Brucella species. Baykam N, Esener H, Ergönül O, Eren S, Celikbas AK, Dokuzoguz B. Int J Antimicrob Agents; 2004 Apr; 23(4):405-7. PubMed ID: 15081093 [Abstract] [Full Text] [Related]
5. Tigecycline: its potential for treatment of brucellosis. Dizbay M, Kilic S, Hizel K, Arman D. Scand J Infect Dis; 2007 Apr; 39(5):432-4. PubMed ID: 17464866 [Abstract] [Full Text] [Related]
6. In vitro activities of various antimicrobials against Brucella melitensis strains in the Aegean region in Turkey. Yamazhan T, Aydemir S, Tünger A, Serter D, Gökengin D. Med Princ Pract; 2005 Apr; 14(6):413-6. PubMed ID: 16220015 [Abstract] [Full Text] [Related]
7. Molecular epidemiological and antibiotic susceptibility characterization of Brucella isolates from humans in Sicily, Italy. Marianelli C, Graziani C, Santangelo C, Xibilia MT, Imbriani A, Amato R, Neri D, Cuccia M, Rinnone S, Di Marco V, Ciuchini F. J Clin Microbiol; 2007 Sep; 45(9):2923-8. PubMed ID: 17634297 [Abstract] [Full Text] [Related]
8. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015. Deshmukh A, Hagen F, Sharabasi OA, Abraham M, Wilson G, Doiphode S, Maslamani MA, Meis JF. BMC Microbiol; 2015 Jun 16; 15():121. PubMed ID: 26073177 [Abstract] [Full Text] [Related]
10. [Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures]. Keşli R, Bilgin H, Yılmaz H. Mikrobiyol Bul; 2017 Jul 16; 51(3):260-268. PubMed ID: 28929962 [Abstract] [Full Text] [Related]
11. Antimicrobial susceptibility testing of Brucella melitensis isolated from patients with acute brucellosis in a centre of Iran. Razzaghi R, Rastegar R, Momen-Heravi M, Erami M, Nazeri M. Indian J Med Microbiol; 2016 Jul 16; 34(3):342-5. PubMed ID: 27514957 [Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility of Brucella melitensis isolates in Peru. Maves RC, Castillo R, Guillen A, Espinosa B, Meza R, Espinoza N, Núñez G, Sánchez L, Chacaltana J, Cepeda D, González S, Hall ER. Antimicrob Agents Chemother; 2011 Mar 16; 55(3):1279-81. PubMed ID: 21199926 [Abstract] [Full Text] [Related]
13. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis. Kilic S, Dizbay M, Cabadak H. J Chemother; 2008 Feb 16; 20(1):33-7. PubMed ID: 18390405 [Abstract] [Full Text] [Related]
14. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China. Liu ZG, Di DD, Wang M, Liu RH, Zhao HY, Piao DR, Zhao ZZ, Hao YQ, Du YN, Jiang H, Cui BY, Xia XZ. BMC Infect Dis; 2018 Jan 16; 18(1):43. PubMed ID: 29338693 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility of Brucella melitensis in Kazakhstan. Shevtsov A, Syzdykov M, Kuznetsov A, Shustov A, Shevtsova E, Berdimuratova K, Mukanov K, Ramankulov Y. Antimicrob Resist Infect Control; 2017 Jan 16; 6():130. PubMed ID: 29299304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]